Highline Wealth Partners’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-150
Closed -$2.16K 1077
2025
Q3
$2.16K Buy
+150
New +$2.13K ﹤0.01% 836

Other funds holding BMEZ

Highline Wealth Partners's BMEZ Position: Q4 2025 in Review

Highline Wealth Partners sold out of BlackRock Health Sciences Trust II (BMEZ) in Q4 2025, closing a stake of 150 shares — an estimated $2.16K sold.

Highline Wealth Partners first reported a position in BMEZ in Q3 2025 and held it in 1 quarter. The position peaked at $2.16K in Q3 2025. 86 funds tracked by Wall St. Rank hold BMEZ as of Q4 2025.

  • Highline Wealth Partners reported no remaining BlackRock Health Sciences Trust II position as of Q4 2025 after selling out during the quarter.
  • Highline Wealth Partners sold 150 BlackRock Health Sciences Trust II shares in Q4 2025, an estimated $2.16K.
  • Highline Wealth Partners first reported a position in BlackRock Health Sciences Trust II in Q3 2025 and held it in 1 quarter.
  • Highline Wealth Partners's BlackRock Health Sciences Trust II position peaked at $2.16K in Q3 2025.
  • 86 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q4 2025.

Based on Highline Wealth Partners's 13F filing for Q4 2025, filed 15 Jan 2026.